Clinical Trial Update: Doravirine Versus Integrase Inhibitors on Backbone of Emtricitabine and Tenofovir Alafenamide in HIV [EARLY_Phase 1]

View source ↗

Summary

An early-phase 1 trial comparing doravirine to integrase inhibitors on a fixed backbone of emtricitabine and tenofovir alafenamide in HIV-1 infection has been c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Disease
• HIV Infection
• Hyperlipidemia

Drugs mentioned

• Doravirine (doravirine)
• Integrase inhibitors (class) (Integrase inhibitor)

Snippet

Sponsor: University of Texas Southwestern Medical Center | Conditions: HIV I Infection, Cardiovascular Risk Factor | EARLY_Phase 1 | Status: COMPLETED